XPhyto Files Patent Application for Library of Novel Psychedelic Compounds
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / September 20, 2022 /XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has filed…